Title : Therapeutic Effect Of First-Line EGFR-TKIs Combined With Concurrent Cranial Radiotherapy On NSCLC Patients With EGFR Activating Mutation And Brain Metastasis: A Retrospective Study.

Pub. Date : 2019

PMID : 31632080






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 It is still controversial whether cranial radiotherapy could be delayed when the EGFR-tyrosine kinase inhibitors (TKIs) used as first-line therapy for EGFR-positive patients with BM. Tyrosine epidermal growth factor receptor Homo sapiens